Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$554M |
| 2 |
Microsoft
MSFT
|
+$470M |
| 3 |
Apple
AAPL
|
+$398M |
| 4 |
Amazon
AMZN
|
+$389M |
| 5 |
Merck
MRK
|
+$306M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$477M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
Philip Morris
PM
|
+$240M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$228M |
Sector Composition
| 1 | Technology | 26.15% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
3376
DELISTED
DermTech, Inc. Common Stock
DMTK
| $943K | ﹤0.01% |
256,219
+1,795
| +0.7% | +$6.61K |
|
3377
Akebia Therapeutics
AKBA
$793M
| $943K | ﹤0.01% |
1,682,498
| – | – |
|
3378
ProPhase Labs
PRPH
$21.4M
| $937K | ﹤0.01% |
123,030
| – | – |
|
3379
NL Industries
NL
$304M
| $937K | ﹤0.01% |
154,540
+11,842
| +8% | +$71.8K |
|
3380
Kopin
KOPN
$366M
| $934K | ﹤0.01% |
857,089
+68,844
| +9% | +$75K |
|
|
SUP
3381
DELISTED
Superior Industries International
SUP
| $933K | ﹤0.01% |
188,514
+919
| +0.5% | +$4.55K |
|
3382
INmune Bio
INMB
$52.4M
| $928K | ﹤0.01% |
143,657
+660
| +0.5% | +$4.26K |
|
3383
Arena Group
AREN
$272M
| $926K | ﹤0.01% |
217,974
+13,273
| +6% | +$56.4K |
|
3384
Natural Gas Services Group
NGS
$334M
| $925K | ﹤0.01% |
89,685
+1
| +0% | +$10 |
|
3385
Inseego
INSG
$208M
| $924K | ﹤0.01% |
158,722
+373
| +0.2% | +$2.17K |
|
3386
Ambev
ABEV
$35.7B
| $924K | ﹤0.01% |
327,676
+20,591
| +7% | +$58.1K |
|
3387
Scilex Holding
SCLX
$176M
| $924K | ﹤0.01% |
3,219
+2,881
| +852% | +$827K |
|
|
BITF
3388
Bitfarms
BITF
$1.13B
| $924K | ﹤0.01% |
952,421
+93,445
| +11% | +$90.6K |
|
|
HYPD
3389
Hyperion DeFi, Inc. Common Stock
HYPD
$68.3M
| $918K | ﹤0.01% |
3,251
| – | – |
|
|
PLM
3390
DELISTED
PolyMet Mining Corp.
PLM
| $916K | ﹤0.01% |
425,950
+156,494
| +58% | +$336K |
|
3391
Spruce Power Holding Corp
SPRU
$29.8M
| $915K | ﹤0.01% |
139,423
+5,292
| +4% | +$34.7K |
|
|
BCLI
3392
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $910K | ﹤0.01% |
18,380
+133
| +0.7% | +$6.58K |
|
3393
American Resources Corp
AREC
$179M
| $908K | ﹤0.01% |
605,048
| – | – |
|
3394
Stereotaxis
STXS
$262M
| $907K | ﹤0.01% |
444,787
| – | – |
|
3395
Granite Ridge Resources
GRNT
$710M
| $899K | ﹤0.01% |
153,225
+47,626
| +45% | +$280K |
|
|
RMGC
3396
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $899K | ﹤0.01% |
89,679
+1,584
| +2% | +$15.9K |
|
|
HIVE
3397
HIVE Digital Technologies
HIVE
$776M
| $899K | ﹤0.01% |
273,124
+20,421
| +8% | +$67.2K |
|
3398
NeueHealth
NEUE
$60.9M
| $895K | ﹤0.01% |
50,762
+1,412
| +3% | +$24.9K |
|
3399
Twin Disc
TWIN
$187M
| $891K | ﹤0.01% |
92,589
| – | – |
|
|
VIA
3400
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $889K | ﹤0.01% |
48,371
+4,612
| +11% | +$84.8K |
|